financetom
Business
financetom
/
Business
/
Marvell Technology Confident in AWS Relationship, AI Accelerator Focus, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marvell Technology Confident in AWS Relationship, AI Accelerator Focus, Oppenheimer Says
May 30, 2025 12:07 PM

02:53 PM EDT, 05/30/2025 (MT Newswires) -- Marvell Technology ( MRVL ) remains confident in its multi-generational relationship with Amazon.com's ( AMZN ) Amazon Web Services and is actively involved in next-generation AI accelerator projects, Oppenheimer said.

Data center revenue growth was driven by AI custom chips and optical products, which now account for more than half of Marvell's ( MRVL ) data center segment and nearly 40% of total revenue. The firm said in a Thursday note that it expects AI-driven revenue to surpass 50% of Marvell's ( MRVL ) total revenue in the near future.

Oppenheimer said Marvell ( MRVL ) has announced four major AI custom chip design wins across Amazon ( AMZN ), Microsoft ( MSFT ) , Google, and Meta Platforms (META).

The firm said AWS is ramping Trainium2 this year, with unit volumes potentially reaching one million, while Microsoft's ( MSFT ) Maia accelerator, built on a 3nm process, is set to begin ramping in calendar 2026. The brokerage believes Marvell ( MRVL ) is already in early discussions for Trainium4, the next generation of AWS's custom silicon.

Oppenheimer said the company maintains a leadership position in high-speed optical products and is developing new technology to support 3.2 terabit-per-second solutions, further strengthening its competitive edge.

The firm reiterated its outperform rating on Marvell's ( MRVL ) stock with a $95 price target.

Price: 59.28, Change: -4.45, Percent Change: -6.98

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Netapp Insider Sold Shares Worth $1,535,614, According to a Recent SEC Filing
Netapp Insider Sold Shares Worth $1,535,614, According to a Recent SEC Filing
Mar 14, 2024
04:22 PM EDT, 03/14/2024 (MT Newswires) -- Michael J Berry, Executive Vice President, CFO, on March 12, 2024, sold 15,000 shares in Netapp ( NTAP ) for $1,535,614. Following the Form 4 filing with the SEC, Berry has control over a total of 144,909 shares of the company, with 144,909 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1002047/000095017024031507/xslF345X03/ownership.xml Price: 102.2, Change: +0.07, Percent...
Phreesia Fiscal Q4 Net Loss Narrows, Revenue Increases; FY 2025 Revenue Outlook Maintained; Shares Rise After Hours
Phreesia Fiscal Q4 Net Loss Narrows, Revenue Increases; FY 2025 Revenue Outlook Maintained; Shares Rise After Hours
Mar 14, 2024
04:22 PM EDT, 03/14/2024 (MT Newswires) -- Phreesia ( PHR ) reported a fiscal Q4 net loss Thursday of $0.56 per diluted share, narrowing from the $0.72 loss a year earlier. Analysts polled by Capital IQ expected a loss of $0.56. Revenue in the quarter ended Jan. 31 rose to $95 million from $76.6 million a year earlier. Analysts surveyed...
Lyondellbasell Industries Insider Sold Shares Worth $1,708,219, According to a Recent SEC Filing
Lyondellbasell Industries Insider Sold Shares Worth $1,708,219, According to a Recent SEC Filing
Mar 14, 2024
04:22 PM EDT, 03/14/2024 (MT Newswires) -- Michael C. McMurray, Executive Vice President & CFO, on March 12, 2024, sold 16,940 shares in Lyondellbasell Industries ( LYB ) for $1,708,219. Following the Form 4 filing with the SEC, McMurray has control over a total of 88,858 shares of the company, with 88,858 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1489393/000156218024002684/xslF345X03/primarydocument.xml Price: 99,...
Apellis Pharmaceuticals Insider Sold Shares Worth $645,838, According to a Recent SEC Filing
Apellis Pharmaceuticals Insider Sold Shares Worth $645,838, According to a Recent SEC Filing
Mar 14, 2024
04:21 PM EDT, 03/14/2024 (MT Newswires) -- Nur Nicholson, Chief Technical Officer, on March 13, 2024, sold 11,220 shares in Apellis Pharmaceuticals ( APLS ) for $645,838. Following the Form 4 filing with the SEC, Nicholson has control over a total of 56,287 shares of the company, with 56,287 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1492422/000112760224010127/xslF345X03/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved